DJIA 17,042.90 -28.32 -0.17%
NASDAQ 4,493.39 -12.46 -0.28%
S&P 500 1,972.29 -5.51 -0.28%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

140.46 0.39 (0.28%)

REAL-TIME: Last trade at

Extended Hours: $140.46 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

AMGN $140.46 0.28%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $140.31
Previous Close $140.07
Daily Range $139.02 - $141.58
52-Week Range $105.76 - $144.46
Market Cap $106.7B
P/E Ratio 21.45
Dividend (Yield) $2.44 (1.7%)
Ex-Dividend Date
Dividend Pay Date
08/12/14
09/05/14
Volume 2,618,267
Average Daily Volume 2,864,693
Current FY EPS $8.24

Sector

Healthcare

Industry

Drugs

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary

3 Top Dividend Growth Stocks to Buy in October

Looking for income AND growth? Check these top picks out.

Amgen, Inc. Showing Strong Performance Despite Low Beta

Celgene Has A Very Bright Future Ahead

AMGN, ACT And GILD, Pushing Drugs Industry Downward

Notable ETF Inflow Detected - XLV, JNJ, AMGN, BMY

3 Likely Biotech Buyout Candidates

'Tax Inversions' Are Tip Of An Iceberg That Already Cost The U.S. Treasury Hundreds Of Billions

Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog

Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog

'Fast Money' Recap: How to Trade After the Market's Drop

Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog

Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog

BioMarin (BMRN) Faces Threat of Genericization for Kuvan - Analyst Blog

See More AMGN News...

AMGN's Top Competitors

AMGN $140.46 (0.28%)
Current stock: AMGN
GILD $106.45 (-0.99%)
Current stock: GILD
CELG $94.78 (-0.90%)
Current stock: CELG
$0.00 (0.00%)
Current stock: